Sayre Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 32

Employees
  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1M

  • Investors
  • 3

Sayre Therapeutics General Information

Description

Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The company's platform facilitates the development and registration of novel drugs, drug-delivery devices, and companion diagnostics, enabling pharmaceutical companies to commercialize proprietary drugs and medicines for the treatment of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Number 91, 3rd Floor, G.R. Square
  • Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
  • Bangalore, Karnataka 560071
  • India
+91 080 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sayre Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 05-Sep-2017 $1M 00.00 Completed Generating Revenue
2. Early Stage VC 04-Sep-2017 00.000 00.000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 07-Apr-2015 $3.97M $3.97M 00.000 Completed Generating Revenue
To view Sayre Therapeutics’s complete valuation and funding history, request access »

Sayre Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Preference 79,800 $0.156163 $48.41 $48.41 1x $48.41 34.7%
To view Sayre Therapeutics’s complete cap table history, request access »

Sayre Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The co
Drug Discovery
Bangalore, India
32 As of 2022
00.00
0000000000 0 00.00

000000

ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000 000000000
Delhi, India
00 As of 0000
00.000
00000000000 00.000

000000

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim v
000000000000000
Pune, India
0000 As of 0000
00.000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sayre Therapeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Invictus Oncology Venture Capital-Backed Delhi, India 00 00.000 00000000000 00.000
000000 Private Equity-Backed Pune, India 0000 00.000 00000000
00000 000000000000 Private Equity-Backed Ahmedabad, India 00000 000.00 00000000000 000.00
000 000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
To view Sayre Therapeutics’s complete competitors history, request access »

Sayre Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Shukrit Chimote Co-Founder, Chief Executive Officer & Board Member
Rajesh Sasidharan Head of Finance & Administration, Manager of Human resources & Administration & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Sayre Therapeutics Board Members (3)

Name Representing Role Since
Mahendran Balachandran Accel Board Member 000 0000
Rajesh Sasidharan Sayre Therapeutics Head of Finance & Administration, Manager of Human resources & Administration & Board Member 000 0000
Shukrit Chimote Sayre Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Sayre Therapeutics’s complete board members history, request access »

Sayre Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sayre Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
InnoVen Capital Lender/Debt Provider Minority 000 0000 000000 0
Aarin Capital Partners Venture Capital Minority 000 0000 000000 0
Accel Venture Capital Minority 000 0000 000000 0
To view Sayre Therapeutics’s complete investors history, request access »